Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  AstraZeneca PLC    AZN   GB0009895292

ASTRAZENECA PLC

(AZN)
  Report
Real-time Estimate Quote. Real-time Estimate CHI-X - 12/02 11:30:00 am
7943 GBX   +1.83%
11:18aWho, when and how? A look at the UK's vaccination rollout
AQ
11:05aHow the U.K. Beat the U.S. and Europe to a Covid-19 Vaccine
DJ
09:29aASTRAZENECA : Crestor to be divested to Grunenthal in Europe
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization1 87 52894 860132 331137 368--
Entreprise Value (EV)1 102 011109 142144 340150 549148 862146 203
P/E ratio 29,2x44,0x97,9x44,0x30,6x22,3x
Yield 4,05%3,74%2,78%2,69%2,72%2,78%
Capitalization / Revenue 3,90x4,29x5,43x5,18x4,56x4,04x
EV / Revenue 4,54x4,94x5,92x5,68x4,95x4,30x
EV / EBITDA 15,2x15,3x21,6x18,8x15,0x11,8x
Price to Book 5,85x7,61x10,00x10,7x9,95x8,35x
Nbr of stocks (in thousands) 1 265 9821 266 8121 311 9131 312 315--
Reference price (USD) 69,174,9101105105105
Last update 02/02/201802/14/201902/14/202012/01/202012/01/202012/01/2020
1 USD in Million
Estimates
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales1 22 46522 09024 38426 49430 09933 962
EBITDA1 6 7137 1406 6868 0129 90112 354
Operating profit (EBIT)1 6 8555 6726 4367 4279 12411 195
Operating Margin 30,5%25,7%26,4%28,0%30,3%33,0%
Pre-Tax Profit (EBT)1 2 2271 9931 5483 8836 1748 880
Net income1 3 0012 1551 3352 9984 4906 251
Net margin 13,4%9,76%5,47%11,3%14,9%18,4%
EPS2 2,371,701,032,383,424,70
Dividend per Share2 2,802,802,802,812,842,91
Last update 02/02/201802/14/201902/14/202012/01/202012/01/202012/01/2020
1 USD in Million
2 USD
Estimates
Balance Sheet Analysis
Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt1 14 48314 28212 00913 18111 4948 835
Net Cash position1 ------
Leverage (Debt / EBITDA) 2,16x2,00x1,80x1,65x1,16x0,72x
Free Cash Flow1 2 2521 5751 9904 0256 2717 997
ROE (Net Profit / Equities) 36,4%32,0%35,6%40,9%50,8%57,7%
Shareholders' equity1 8 2506 7423 7527 3308 84210 826
ROA (Net Profit / Asset) 4,77%7,07%2,19%7,10%9,15%13,4%
Assets1 62 94030 48061 01542 22649 07546 647
Book Value Per Share2 11,89,8410,19,7810,512,5
Cash Flow per Share2 2,822,072,283,345,226,73
Capex1 1 3261 0439791 1131 2111 328
Capex / Sales 5,90%4,72%4,01%4,20%4,02%3,91%
Last update 02/02/201802/14/201902/14/202012/01/202012/01/202012/01/2020
1 USD in Million
2 USD
Estimates
Finances - Leverage
Financial data source
© 2020 S&P Global Market Intelligence
Key data
Capitalization (GBP)
102 360 607 596
Capitalization (USD)
137 452 138 574
Net sales (USD)
24 384 000 000
Number of employees
70 600
Sales / Employee (USD)
345 382
Free-Float
95,7%
Free-Float capitalization (GBP)
98 008 904 763
Free-Float capitalization (USD)
131 608 573 605
Avg. Exchange 20 sessions (USD)
20 417 188 406
Average Daily Capital Traded
19,9%
EPS & Dividend